FDA Adverse Event Injury Summary report: N

GMK-SPHERE TIBIAL INSERT FIXED SPHERE FLEX SIZE 3/12 MM R

MDR report key: 11025983 · Received December 17, 2020

Report

Report Number
3005180920-2020-00906
Event Type
Injury
Date Received
December 17, 2020
Date of Event
November 18, 2020
Report Date
December 17, 2020
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630030826382
PMA / PMN Number
K121416
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

BATCH REVIEW PERFORMED ON 28 NOVEMBER 2020. LOT#: 163070: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 04-AUG-2016. EXPIRATION DATE: 2021-07-21. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT. CLINICAL EVALUATION PERFORMED BY MEDICAL AFFAIRS MANAGER: INSERT REVISION AND PATELLA RESURFACING IN TKA 3 YEARS AND 10 MONTHS AFTER PRIMARY FOR JOINT INSTABILITY AND PAIN. THE INSERT WAS EXCHANGED TO A THICKER ONE. THE DEVELOPMENTAL INSTABILITY IS A RATHER COMMONLY DESCRIBED POSSIBLE COMPLICATION FOLLOWING TKA, BECAUSE SOFT TISSUE MAY STRETCH AND PROVIDE INSUFFICIENT STABILITY. IT IS THEREFORE, COMMON PRACTICE TO RESORT TO A THICKER INSERT AND RECREATE SOFT TISSUE TENSION. A SECONDARY PATELLAR RESURFACING SHOULD NOT BE CONSIDERED A FAILURE: SOMETIMES SURGEONS PREFER TO POSTPONE PATELLA ARTHROPLASTY IN ORDER TO PRESERVE MAXIMUM QUANTITY OF BONE AND REDUCE TRAUMA, AND PROCEED TO TREAT ONLY IN CASE OF PERSISTENT ANTERIOR PAIN. THIS IS NOT A PROBLEM DUE TO ANY IMPLANT DEFECT OR MALFUNCTION.

Description of Event or Problem · 1

THE PATIENT HAD PAIN AND THE KNEE WASN'T STABLE, THEREFORE, THE SURGEON DECIDED TO CHANGE TO A THICKER INLAY AND PUT A PATELLA (3 YEARS AND 10 MONTHS AFTER PRIMARY SURGERY).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1493588 GMK-SPHERE TIBIAL INSERT FIXED SPHERE FLEX SIZE 3/12 MM R TIBIAL INSERT JWH MEDACTA INTERNATIONAL SA 02.12.0312FR 163070 07630030826382

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention